[{"id":"afb54b00-dd72-450d-8e47-e3e7bae4cf8e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05264974","created_at":"2022-03-03T13:28:10.249Z","updated_at":"2024-07-02T16:34:26.461Z","phase":"Phase 1","brief_title":"Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy","source_id_and_acronym":"NCT05264974","lead_sponsor":"University of Florida","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF wild-type","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RNA-NP vaccine"],"overall_status":"Suspended","enrollment":" Enrollment 18","initiation":"Initiation: 06/01/2024","start_date":" 06/01/2024","primary_txt":" Primary completion: 09/01/2026","primary_completion_date":" 09/01/2026","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-06-13"}]